Central Trust CO Penumbra Inc Transaction History

Central Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	BUY	$220.43 - $278.69 $5,510 - $6,967	25 New	25 $6,000
Q2 2022 Aug 09, 2022	SELL	$116.09 - $227.33 $17,413 - $34,099	-150 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$174.98 - $272.83 $46,719 - $72,845	-267 Reduced 64.03%	150 $26,000
Q3 2020 Oct 22, 2020	SELL	$185.27 - $238.73 $76,887 - $99,072	-415 Reduced 49.88%	417 $81,000
Q2 2020 Jul 14, 2020	SELL	$153.32 - $191.72 $5,059 - $6,326	-33 Reduced 3.82%	832 $148,000
Q1 2020 Apr 17, 2020	SELL	$124.34 - $193.76 $2,486 - $3,875	-20 Reduced 2.26%	865 $139,000
Q4 2019 Jan 21, 2020	SELL	$134.81 - $177.8 $44,756 - $59,029	-332 Reduced 27.28%	885 $145,000
Q3 2019 Oct 28, 2019	BUY	$131.82 - $183.4 $29,791 - $41,448	226 Added 22.81%	1,217 $164,000
Q2 2019 Jul 12, 2019	BUY	$124.65 - $167.39 $123,528 - $165,883	991 New	991 $0

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.